Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV002475321 | SCV002771743 | pathogenic | not provided | 2022-06-06 | criteria provided, single submitter | clinical testing | This variant has been identified in at least one individual with CADASIL. This variant has not been reported in large, multi-ethnic general populations (http://gnomad.broadinstitute.org). This variant results in the same amino acid change as c.128G>A, which composes part of this deletion insertion, and is also classified as pathogenic when observed alone. Additionally, one other missense variant affects this codon and is classified as pathogenic (c.128G>T; p.Cys43Phe). This variant alters a critical location within the protein, and is expected to severely affect function and cause disease. Greater than 90% of pathogenic variants identified in NOTCH3 involve the gain or loss of a cysteine residue within the epidermal growth factor (EGF)-like repeat domain. |